We are live on ! Find out more

1,154 hedge funds and large institutions have $69.9B invested in Amgen in 2013 Q4 according to their latest regulatory filings, with 144 funds opening new positions, 412 increasing their positions, 439 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

251% more first-time investments, than exits

New positions opened: 144 | Existing positions closed: 41

9% more funds holding

Funds holding: 1,0621,154 (+92)

2% more capital invested

Capital invested by funds: $68.3B → $69.9B (+$1.6B)

6% less repeat investments, than reductions

Existing positions increased: 412 | Existing positions reduced: 439

11% less funds holding in top 10

Funds holding in top 10: 5751 (-6)

25% less call options, than puts

Call options by funds: $620M | Put options by funds: $822M

Holders
1,154
Holders Change
+92
Holders Change %
+8.66%
% of All Funds
33.49%
Holding in Top 10
51
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-10.53%
% of All Funds
1.48%
New
144
Increased
412
Reduced
439
Closed
41
Calls
$620M
Puts
$822M
Net Calls
-$202M
Net Calls Change
-$46.5M
Name Holding Trade Value Shares
Change
Change in
Stake
Capital Research Global Investors
1
Capital Research Global Investors
California
$8.84B +$1.12B +9,832,857 +15%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$5.46B -$381M -3,352,314 -7%
Vanguard Group
3
Vanguard Group
Pennsylvania
$4.21B +$61.2M +537,915 +1%
Primecap Management
4
Primecap Management
California
$4.05B -$34.6M -303,871 -0.8%
State Street
5
State Street
Massachusetts
$3.58B +$39.9M +351,171 +1%
BIT
6
BlackRock Institutional Trust
California
$2.4B -$5.27M -46,318 -0.2%
Wellington Management Group
7
Wellington Management Group
Massachusetts
$2.15B -$180M -1,585,901 -8%
Invesco
8
Invesco
Georgia
$2.01B +$99.4M +873,985 +5%
Bank of New York Mellon
9
Bank of New York Mellon
New York
$1.33B +$24.6M +216,262 +2%
Northern Trust
10
Northern Trust
Illinois
$1.29B +$8.28M +72,777 +0.6%
BFA
11
BlackRock Fund Advisors
California
$1.24B +$68.2M +599,322 +6%
Franklin Resources
12
Franklin Resources
California
$1.23B -$102M -897,361 -8%
ClearBridge Investments
13
ClearBridge Investments
New York
$982M +$107M +941,632 +12%
BG
14
BlackRock Group
United Kingdom
$682M -$42.1M -370,380 -6%
Ameriprise
15
Ameriprise
Minnesota
$664M +$64.7M +568,872 +11%
Norges Bank
16
Norges Bank
Norway
$649M -$56.8M -499,715 -8%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$647M +$22.3M +195,658 +4%
Winslow Capital Management
18
Winslow Capital Management
Minnesota
$645M +$114M +1,000,396 +21%
TCIM
19
TIAA CREF Investment Management
New York
$608M -$66.2M -581,536 -10%
Boston Partners
20
Boston Partners
Massachusetts
$585M +$1.53M +13,425 +0.3%
T. Rowe Price Associates
21
T. Rowe Price Associates
Maryland
$572M -$247M -2,173,500 -30%
LSV Asset Management
22
LSV Asset Management
Illinois
$471M -$32.8M -288,780 -7%
Deutsche Bank
23
Deutsche Bank
Germany
$446M -$107M -941,611 -19%
Morgan Stanley
24
Morgan Stanley
New York
$414M +$29.7M +261,292 +8%
JHIU
25
Janus Henderson Investors US
Colorado
$402M -$116M -1,021,549 -22%

AMGN Hedge Fund Activity: Q4 2013 in Review

1,154 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Amgen (AMGN) for Q4 2013, worth a combined $69.9B — up 2.3% from $68.3B a quarter earlier.

Buyers outnumbered sellers: 144 funds opened new AMGN positions and 41 closed out — a net gain of 103 holders — while 412 added to existing stakes and 439 trimmed.

The largest buyer was Capital Research Global Investors, adding an estimated $1.12B. The largest seller was Fidelity Investments, cutting an estimated $381M.

  • 1,154 institutional investors held Amgen (AMGN) as of Q4 2013, up from 1,062 in Q3 2013.
  • Funds reported $69.9B of Amgen stock for Q4 2013, up 2.3% quarter-over-quarter.
  • 144 funds opened new Amgen positions in Q4 2013 and 41 closed out, a net change of +103 holders.
  • The largest Amgen buyer in Q4 2013 was Capital Research Global Investors, an estimated $1.12B added.
  • The largest Amgen seller in Q4 2013 was Fidelity Investments, an estimated $381M sold.

Based on aggregated 13F filings for Q4 2013.